Start:
November 1, 2017
End:
October 2019
Enrollment:
56
This study will investigate pupillary light response as a potential detection method for progressive supranuclear palsy (PSP) in adults with PSP or other neurodegenerative diseases.
Minimum Age: 55 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Massachusetts | |
---|---|
Massachusetts General Hospital
Boston,
MA
02114
Recruiting
Shirley H Wray, MD, PhD, FRCP |
Lead: Massachusetts General Hospital
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT03330353
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health